NCT00709254 - Study of Single and Multiple Doses of Inhaled AeroLEF (Liposome-Encapsulated Fentanyl)in Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2001

Primary Completion Date

January 31, 2002

Study Completion Date

January 31, 2002

Conditions

Healthy

Interventions

DRUG

i.v. fentanyl

single dose, 200 ug

DRUG

3 mL AeroLEF (500 µg/1 mL)

A single dose of 3mL (500 µg/1 mL) of AeroLEF (Aerosolized Free and Liposome-Encapsulated Fentanyl)

DRUG

3 mL AeroLEF (500 µg/1 mL)

A multiple doses of 3mL (500 µg/1 mL)of AeroLEF (Aerosolized Free and Liposome-Encapsulated Fentanyl)every 12 hours for a total of five doses over a 3 days

Trial Locations (1)

Unknown

University of Toronto, Toronto